Abstract
Dendritic cells (DCs) are a heterogeneous population of bone marrow-derived antigen-presenting cells (APCs) that populate various lymphoid and nonlymphoid tissues, including the skin (Langerhans cells), lymph nodes (interdigitating and follicular DCs), spleen, and thymus. DCs are considered professional APCs, with a remarkable ability for initiating T-cell activation and the consequent immune response, but also for inducing tolerance (1–3). The regulation of these two distinct functions is not completely understood to date. Extensive recent studies have improved our understanding of DC development, differentiation, activation, and function. DCs exist as distinct subsets that differ in their lineage affiliation, surface molecule expression, and biological function. Each of these types of DCs can present antigens in either an immunogenic or tolerogenic manner according to their maturation state and antigen capture properties. Hence, DCs either induce the appropriate immune response to pathogens or prevent autoimmune reactivity, and could thus be useful for manipulating the immune system by cellular immunotherapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lanzavecchia, A. and Sallusto, F. (2001) Regulation of T cell immunity by dendritic cells. Cell 106, 263–266.
Liu, Y. J. (2001) Dendritic cell subsets and lineages and their functions in innate and adaptive immunity. Cell 106, 259–262.
Mellman, I. and Steinman, R. M. (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255–258.
Banchereau, J., Schuler-Thurner, B., Palucka, A. K., and Schuler, G. (2001) Dendritic cells as vectors for therapy. Cell 106, 271–274.
Gunzer, M., Janich, S., Varga, G., and Grabbe, S. (2001) Dendritic cells and tumor immunity. Semin. Immunol. 13, 291–302.
Sprinzl, G. M., Kacani, L., Schrott-Fischer, A., Romani, N., and Thumfart, W. F. (2001) Dendritic cell vaccines for cancer therapy. Cancer Treat. Rev. 27, 247–255.
Steinman, R. M. and Dhodapkar, M. (2001) Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer 94, 459–473.
Ludewig, B., Junt, T., Hengartner, H., and Zinkernagel, R. M. (2001) Dendritic cells in autoimmune diseases. Curr. Opin. Immunol. 13, 657–662.
Steinman, R. M. and Nussenzweig, M. C. (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99, 351–358.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Segall, H., Sutton, R.E. (2003). Monocyte/Macrophages and Dendritic Cells. In: Federico, M. (eds) Lentivirus Gene Engineering Protocols. Methods in Molecular Biology™, vol 229. Humana Press. https://doi.org/10.1385/1-59259-393-3:107
Download citation
DOI: https://doi.org/10.1385/1-59259-393-3:107
Publisher Name: Humana Press
Print ISBN: 978-1-58829-091-5
Online ISBN: 978-1-59259-393-4
eBook Packages: Springer Protocols